Medical Reviewer
Dr. Jane Novak
MD, MPH
14 years experienceLicensed in CA
Dr. Jane Novak is a board-certified internist and clinical researcher with 14 years of experience focused on metabolic health, pharmacotherapy, and obesity medicine. She practices at UCSF Health in Oakland, California, where she co-directs the GLP-1 prescribing clinic, and serves as a clinical assistant professor at UCSF School of Medicine. Her published work on long-term GLP-1 retention and prior-authorization barriers has appeared in JAMA, NEJM Catalyst, and Obesity Reviews. Dr. Novak is a Diplomate of the American Board of Obesity Medicine and a member of the Obesity Society, ENDO, and the American College of Physicians. On Health Portal she reviews every medication overview and clinical-guidance page for FDA-label accuracy, dosing fidelity, and contraindication coverage before publication.
Areas of focus
- Internal Medicine
- Obesity Medicine
- Metabolic Health
- Endocrinology
- GLP-1 Pharmacotherapy
Education & training
- MD — University of California, San Francisco2011
- MPH (Health Policy & Management) — Johns Hopkins Bloomberg School of Public Health2013
- Residency, Internal Medicine — UCSF Medical Center2014
- Fellowship, Obesity Medicine — Massachusetts General Hospital2016
Current affiliations
- Co-Director, GLP-1 Prescribing Clinic — UCSF Health
- Clinical Assistant Professor — UCSF School of Medicine
- Diplomate — American Board of Obesity Medicine
- Member — The Obesity Society
- Member — American College of Physicians
Verify credentials
Public profiles and external pages confirming credentials, board certification, and published work.
Topical authority
Pages reviewed on this site
Editorial accountability lives here — every page below was reviewed by this clinician.
Providers reviewed
Ro
Direct-to-consumer GLP-1 program with broad medication selection and a polished app.
Hims
Telehealth platform with GLP-1 weight loss as part of a broader wellness lineup.
MEDVi
Physician-led GLP-1 telehealth with insurance billing support.
Sequence (Weight Watchers Clinic)
Weight Watchers-owned medical weight loss platform combining GLP-1s with coaching.
Found
Personalized weight-loss program offering GLP-1s plus non-GLP-1 alternatives.
Selected publications
- Long-term retention on semaglutide for chronic weight management: a real-world cohort study
JAMA Internal Medicine, 2024
- Prior-authorization barriers to GLP-1 therapy in commercial-insurance populations
NEJM Catalyst, 2023
- Comparative effectiveness of tirzepatide versus semaglutide in patients with type 2 diabetes
Obesity Reviews, 2025